Document is current
Any future updates will be listed below
-
Authors
Soen, Satoshi
Kaku, Miki
Okubo, Naoki
Touzeni, Salsabil
Saito, Kengo
Kobayashi, Makiko
-
Funding
Funding for this research was provided by:
Daiichi Sankyo Co. Ltd.
- License Information
-
More Information
Article History
Received: 31 March 2021
Accepted: 5 May 2021
First Online: 14 June 2021
Declarations
:
: SS has received consulting fees, speaking fees or honoraria from Asahi Kasei Pharma, Astellas, Amgen, Daiichi Sankyo, Eli Lilly Japan, and UCB Japan. MK, NO, KS, and MK are employees of Daiichi Sankyo, a pharmaceutical company which markets medications for the treatment of osteoporosis. ST is an employee of Creativ-Ceutical, a consultancy company who received funding from Daiichi Sankyo for the implementation of this study.
